Pixium logs German reimbursement win for Iris II ‘bionic eye’


Pixium logs German reimbursement win for Iris II 'bionic eye'Pixium Vision (EPA:PIX) said today that its Iris II ‘bionic eye’ won NUB 1 reimbursement status from the German Institute for the Hospital Remuneration System.

The company’s epi-retinal implant has 150 electrodes and a bio-inspired camera intended for patients who have lost sight due to retinitis pigmentosa. A computer processes images captured by the camera and transmits the data into a signal that’s transferred back and projected onto the intraocular implant. The incoming signal stimulates the optic nerve and generates images that the brain can interpret as visual signals.

Get the full story at our sister site, MassDevice.

Hear from top executives at Abbott, Google, Boston Scientific, Medtronic and more at DeviceTalks Minnesota, June 4–5 in St. Paul.

Speak Your Mind